IDEXX Laboratories Elects Irene Chang Britt to Board of Directors
12 Juillet 2023 - 1:00PM
Business Wire
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet
healthcare innovation, today announced the election of Irene Chang
Britt, a former executive at Campbell Soup Company, to the
Company's Board of Directors, effective July 11, 2023.
"We are pleased to welcome Irene to the IDEXX Board of
Directors," said Larry Kingsley, the Company's Independent
Non-Executive Board Chair. "Irene is a seasoned executive and
director who brings a wealth of business, strategic and leadership
experience from her prior senior management roles at public
companies, as well as valuable perspectives from her service on
public and private company boards. We are confident she will be a
strong contributor on our Board."
"I am excited to join the board of a purpose-driven company
focused on pet healthcare innovation," said Ms. Chang Britt. "I
look forward to working closely with my fellow directors and the
IDEXX leadership team to deliver on our Purpose to enhance the
health and well-being of pets, people, and livestock while creating
long-term value for our stakeholders."
Ms. Chang Britt was most recently an executive at Campbell Soup
Company, a global food and beverage company, where she held roles
of increasing scope and responsibility over 10 years, including
serving as President/Divisional CEO, Pepperidge Farm Ltd. and
Senior Vice President, Global Baking and Snacking; and Senior Vice
President and Chief Strategy Officer. Prior to her time at Campbell
Soup Company, she held various roles at Kraft Foods, Nabisco, and
Kimberly-Clark.
Ms. Chang Britt currently serves as an independent director of
Brighthouse Financial, Inc., a provider of annuities and life
insurance, and Victoria’s Secret & Co., a clothing and beauty
retailer. She previously served as a director of Tailored Brands,
Inc., Dunkin’ Brands Group, Inc., TerraVia Holdings, Inc., and
Sunoco, Inc.
Ms. Chang Britt received her undergraduate degree in
Anthropology from the University of Toronto and her MBA from the
University of Western Ontario.
About IDEXX Laboratories
IDEXX is a global leader in pet healthcare innovation. Our
diagnostic and software products and services create clarity in the
complex, constantly evolving world of veterinary medicine. We
support longer, fuller lives for pets by delivering insights and
solutions that help the veterinary community around the world make
confident decisions—to advance medical care, improve efficiency,
and build thriving practices. Our innovations also help ensure the
safety of milk and water across the world and maintain the health
and well-being of people and livestock. IDEXX Laboratories, Inc. is
a member of the S&P 500® Index. Headquartered in Maine, IDEXX
employs nearly 11,000 people and offers solutions and products to
customers in more than 175 countries. For more information about
IDEXX, visit: www.idexx.com. For media inquiries, please get in
touch at media@idexx.com.
Note Regarding Forward-Looking Statements
This news release contains or may contain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements can be identified by
the use of words such as “expects,” “may,” “anticipates,”
“intends,” “would,” “will,” “plans,” “believes,” “estimates,”
“should,” “project,” and similar words and expressions. These
forward-looking statements are intended to provide our current
expectations or forecasts of future events; are based on current
estimates, projections, beliefs, and assumptions; and are not
guarantees of future performance. Actual events or results may
differ materially from those described in the forward-looking
statements. These statements are subject to risks, uncertainties,
assumptions, and other important factors. Readers are cautioned not
to put undue reliance on such forward-looking statements because
actual results may vary materially from those expressed or implied.
The reports filed by IDEXX pursuant to United States securities
laws contain discussions of some of these risks and uncertainties.
IDEXX assumes no obligation to, and expressly disclaims any
obligation to, update or revise any forward-looking statements,
whether as a result of new information, future events, or
otherwise. Readers are advised to review IDEXX’s filings with the
United States Securities and Exchange Commission (which are
available from the SEC’s EDGAR database at sec.gov and via IDEXX’s
website at idexx.com).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230711078437/en/
Investor Relations John Ravis 1-207-556-8155
investorrelations@idexx.com
IDEXX Laboratories (NASDAQ:IDXX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
IDEXX Laboratories (NASDAQ:IDXX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024